Page last updated: 2024-11-07

perlolyrine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

perlolyrine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID160179
CHEMBL ID501991
CHEBI ID69444
SCHEMBL ID3919519
MeSH IDM0156839

Synonyms (29)

Synonym
inchi=1/c16h12n2o2/c19-9-10-5-6-14(20-10)16-15-12(7-8-17-16)11-3-1-2-4-13(11)18-15/h1-8,18-19h,9h
C09231
perlolyrine
29700-20-7
ccris 4068
2-furanmethanol, 5-(9h-pyrido(3,4-b)indol-1-yl)-
CHEMBL501991
perlolyrin
chebi:69444 ,
[5-(9h-pyrido[3,4-b]indol-1-yl)furan-2-yl]methanol
unii-sv3l654t9s
yellow substance ys
substance ys
sv3l654t9s ,
SCHEMBL3919519
KFUCYPGCMLPUMT-UHFFFAOYSA-N
[5-(9h-beta-carbolin-1-yl)-2-furyl]methanol #
(5-{9h-pyrido[3,4-b]indol-1-yl}furan-2-yl)methanol
2-(b-carbolin-1-yl)-5-hydroxymethylfuran
alkaloid ys
5-(9h-pyrido[3,4-b]indol-1-yl)-2-furanmethanol, 9ci
5-(9h-pyrido(3,4-b)indol-1-yl)-2-furanmethanol
[5-(9h-beta-carbolin-1-yl)-2-furyl]methanol
FS-8377
Q27104974
DTXSID50903330
bdbm50458321
2-furanmethanol, 5-(9h-pyrido[3,4-b]indol-1-yl)-
AKOS040763548

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"The plasma concentration and pharmacokinetic parameters of perlolyrine were determined by gas chromatography-mass spectrometry (GC-MS) with selected ion (m/z 247 and m/z 248) and [2-(15) N] perlolyrine (m/z 248) as internal standard."( Pharmacokinetics of perlolyrine in rats by stable isotope dilution in conjunction with GC-MS.
Jiang, GH; Tang, GH; Zheng, LF, 2000
)
0.87
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)IC50 (µMol)9.30000.00001.18439.6140AID1383528; AID1421850
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (10)

Processvia Protein(s)Taxonomy
positive regulation of cardiac muscle hypertrophycGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
regulation of nitric oxide mediated signal transductioncGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
T cell proliferationcGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
negative regulation of T cell proliferationcGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
cGMP catabolic processcGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
oocyte developmentcGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
negative regulation of cardiac muscle contractioncGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
relaxation of cardiac musclecGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
positive regulation of oocyte developmentcGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
cAMP-mediated signalingcGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
3',5'-cyclic-nucleotide phosphodiesterase activitycGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
protein bindingcGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
cGMP bindingcGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
metal ion bindingcGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
3',5'-cyclic-GMP phosphodiesterase activitycGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
3',5'-cyclic-AMP phosphodiesterase activitycGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
cellular_componentcGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
cytosolcGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID362669Antimicrobial activity against Chlorella vulgaris by agar diffusion test2008Journal of natural products, Sep, Volume: 71, Issue:9
Furan oligomers and beta-carbolines from terrestrial streptomycetes.
AID362665Antimicrobial activity against Streptomyces viridochromogenes Tu57 by agar diffusion test2008Journal of natural products, Sep, Volume: 71, Issue:9
Furan oligomers and beta-carbolines from terrestrial streptomycetes.
AID1421850Inhibition of PDE5 (unknown origin)2018European journal of medicinal chemistry, Oct-05, Volume: 158Discovery of furyl/thienyl β-carboline derivatives as potent and selective PDE5 inhibitors with excellent vasorelaxant effect.
AID362666Antimicrobial activity against Escherichia coli by agar diffusion test2008Journal of natural products, Sep, Volume: 71, Issue:9
Furan oligomers and beta-carbolines from terrestrial streptomycetes.
AID362671Antimicrobial activity against Scenedesmus subspicatus by agar diffusion test2008Journal of natural products, Sep, Volume: 71, Issue:9
Furan oligomers and beta-carbolines from terrestrial streptomycetes.
AID616383Anti-inflammatory activity in human neutrophils assessed as inhibition of FMLP/CB-induced elastase release2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Anti-inflammatory principles from Cordyceps sinensis.
AID362670Antimicrobial activity against Chlorella sorokiniana by agar diffusion test2008Journal of natural products, Sep, Volume: 71, Issue:9
Furan oligomers and beta-carbolines from terrestrial streptomycetes.
AID362668Antimicrobial activity against Mucor miehei by agar diffusion test2008Journal of natural products, Sep, Volume: 71, Issue:9
Furan oligomers and beta-carbolines from terrestrial streptomycetes.
AID616299Anti-inflammatory activity in human neutrophils assessed as inhibition of FMLP/CB-induced superoxide anion generation2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Anti-inflammatory principles from Cordyceps sinensis.
AID1383528Inhibition of PDE5 (unknown origin)
AID362664Antimicrobial activity against Bacillus subtilis by agar diffusion test2008Journal of natural products, Sep, Volume: 71, Issue:9
Furan oligomers and beta-carbolines from terrestrial streptomycetes.
AID362663Antimicrobial activity against Staphylococcus aureus by agar diffusion test2008Journal of natural products, Sep, Volume: 71, Issue:9
Furan oligomers and beta-carbolines from terrestrial streptomycetes.
AID1467207Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction in LPS-induced NO production pretreated for 30 mins followed by LPS stimulation for 24 hrs by Griess assay2017Bioorganic & medicinal chemistry letters, 06-15, Volume: 27, Issue:12
Alkaloids from aerial parts of Houttuynia cordata and their anti-inflammatory activity.
AID616386Antioxidant activity assessed DPPH scavenging activity at 500 uM2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Anti-inflammatory principles from Cordyceps sinensis.
AID362667Antimicrobial activity against Candida albicans by agar diffusion test2008Journal of natural products, Sep, Volume: 71, Issue:9
Furan oligomers and beta-carbolines from terrestrial streptomycetes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (13.33)18.7374
1990's2 (13.33)18.2507
2000's3 (20.00)29.6817
2010's7 (46.67)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.24 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.37 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]